A Pilot Study of Topical Antiflammin-2 for Psoriasis
NCT00001371
·
clinicaltrials.gov ↗
COMPLETED
Status
24
Enrollment
NIH
Sponsor class
Conditions
Psoriasis
Sponsor
National Cancer Institute (NCI)